Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Brain Imaging And Neuroimaging Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Brain Imaging And Neuroimaging Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 144 Pages
Report ld: 5347444
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Brain Imaging And Neuroimaging market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Hospitals accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Brain Imaging And Neuroimaging leading manufacturers including Varian Medical Systems, General Electric, Siemens AG, Philips Healthcare, Toshiba Medical Systems, Hitachi Medical Systems, Esaote SpA, Sanrad Medical Systems, etc., dominate supply; the top five capture approximately % of global revenue, with Varian Medical Systems leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Brain Imaging And Neuroimaging market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Varian Medical Systems
- General Electric
- Siemens AG
- Philips Healthcare
- Toshiba Medical Systems
- Hitachi Medical Systems
- Esaote SpA
- Sanrad Medical Systems
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Functional Magnetic Resonance Imaging (fMRI)
- Computed Tomography (CT)
- Positron Emission Tomography (PET)
Segment by Application
- Hospitals
- Ambulatory Surgical Centers
- Clinics and Diagnostic Centers
CHAPTER OUTLINE
Chapter 1: Defines the Brain Imaging And Neuroimaging study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Brain Imaging And Neuroimaging: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Brain Imaging And Neuroimaging Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Functional Magnetic Resonance Imaging (fMRI)
1.2.3 Computed Tomography (CT)
1.2.4 Positron Emission Tomography (PET)
1.3 Market Segmentation by Application
1.3.1 Global Brain Imaging And Neuroimaging Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Clinics and Diagnostic Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Brain Imaging And Neuroimaging Revenue Estimates and Forecasts 2020-2031
2.2 Global Brain Imaging And Neuroimaging Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Brain Imaging And Neuroimaging Sales Estimates and Forecasts 2020-2031
2.4 Global Brain Imaging And Neuroimaging Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Brain Imaging And Neuroimaging Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Brain Imaging And Neuroimaging Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Functional Magnetic Resonance Imaging (fMRI) Market Size by Manufacturers
3.5.2 Computed Tomography (CT) Market Size by Manufacturers
3.5.3 Positron Emission Tomography (PET) Market Size by Manufacturers
3.6 Global Brain Imaging And Neuroimaging Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Brain Imaging And Neuroimaging Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Brain Imaging And Neuroimaging Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Brain Imaging And Neuroimaging Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Brain Imaging And Neuroimaging Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Brain Imaging And Neuroimaging Sales and Revenue by Type (2020-2031)
6.4 North America Brain Imaging And Neuroimaging Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Brain Imaging And Neuroimaging Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Brain Imaging And Neuroimaging Sales and Revenue by Type (2020-2031)
7.4 Europe Brain Imaging And Neuroimaging Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Brain Imaging And Neuroimaging Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Brain Imaging And Neuroimaging Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Brain Imaging And Neuroimaging Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Brain Imaging And Neuroimaging Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Brain Imaging And Neuroimaging Sales and Revenue by Type (2020-2031)
9.4 Central and South America Brain Imaging And Neuroimaging Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Brain Imaging And Neuroimaging Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Brain Imaging And Neuroimaging Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Brain Imaging And Neuroimaging Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Brain Imaging And Neuroimaging Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Varian Medical Systems
11.1.1 Varian Medical Systems Corporation Information
11.1.2 Varian Medical Systems Business Overview
11.1.3 Varian Medical Systems Brain Imaging And Neuroimaging Product Models, Descriptions and Specifications
11.1.4 Varian Medical Systems Brain Imaging And Neuroimaging Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Varian Medical Systems Brain Imaging And Neuroimaging Sales by Product in 2024
11.1.6 Varian Medical Systems Brain Imaging And Neuroimaging Sales by Application in 2024
11.1.7 Varian Medical Systems Brain Imaging And Neuroimaging Sales by Geographic Area in 2024
11.1.8 Varian Medical Systems Brain Imaging And Neuroimaging SWOT Analysis
11.1.9 Varian Medical Systems Recent Developments
11.2 General Electric
11.2.1 General Electric Corporation Information
11.2.2 General Electric Business Overview
11.2.3 General Electric Brain Imaging And Neuroimaging Product Models, Descriptions and Specifications
11.2.4 General Electric Brain Imaging And Neuroimaging Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 General Electric Brain Imaging And Neuroimaging Sales by Product in 2024
11.2.6 General Electric Brain Imaging And Neuroimaging Sales by Application in 2024
11.2.7 General Electric Brain Imaging And Neuroimaging Sales by Geographic Area in 2024
11.2.8 General Electric Brain Imaging And Neuroimaging SWOT Analysis
11.2.9 General Electric Recent Developments
11.3 Siemens AG
11.3.1 Siemens AG Corporation Information
11.3.2 Siemens AG Business Overview
11.3.3 Siemens AG Brain Imaging And Neuroimaging Product Models, Descriptions and Specifications
11.3.4 Siemens AG Brain Imaging And Neuroimaging Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Siemens AG Brain Imaging And Neuroimaging Sales by Product in 2024
11.3.6 Siemens AG Brain Imaging And Neuroimaging Sales by Application in 2024
11.3.7 Siemens AG Brain Imaging And Neuroimaging Sales by Geographic Area in 2024
11.3.8 Siemens AG Brain Imaging And Neuroimaging SWOT Analysis
11.3.9 Siemens AG Recent Developments
11.4 Philips Healthcare
11.4.1 Philips Healthcare Corporation Information
11.4.2 Philips Healthcare Business Overview
11.4.3 Philips Healthcare Brain Imaging And Neuroimaging Product Models, Descriptions and Specifications
11.4.4 Philips Healthcare Brain Imaging And Neuroimaging Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Philips Healthcare Brain Imaging And Neuroimaging Sales by Product in 2024
11.4.6 Philips Healthcare Brain Imaging And Neuroimaging Sales by Application in 2024
11.4.7 Philips Healthcare Brain Imaging And Neuroimaging Sales by Geographic Area in 2024
11.4.8 Philips Healthcare Brain Imaging And Neuroimaging SWOT Analysis
11.4.9 Philips Healthcare Recent Developments
11.5 Toshiba Medical Systems
11.5.1 Toshiba Medical Systems Corporation Information
11.5.2 Toshiba Medical Systems Business Overview
11.5.3 Toshiba Medical Systems Brain Imaging And Neuroimaging Product Models, Descriptions and Specifications
11.5.4 Toshiba Medical Systems Brain Imaging And Neuroimaging Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Toshiba Medical Systems Brain Imaging And Neuroimaging Sales by Product in 2024
11.5.6 Toshiba Medical Systems Brain Imaging And Neuroimaging Sales by Application in 2024
11.5.7 Toshiba Medical Systems Brain Imaging And Neuroimaging Sales by Geographic Area in 2024
11.5.8 Toshiba Medical Systems Brain Imaging And Neuroimaging SWOT Analysis
11.5.9 Toshiba Medical Systems Recent Developments
11.6 Hitachi Medical Systems
11.6.1 Hitachi Medical Systems Corporation Information
11.6.2 Hitachi Medical Systems Business Overview
11.6.3 Hitachi Medical Systems Brain Imaging And Neuroimaging Product Models, Descriptions and Specifications
11.6.4 Hitachi Medical Systems Brain Imaging And Neuroimaging Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Hitachi Medical Systems Recent Developments
11.7 Esaote SpA
11.7.1 Esaote SpA Corporation Information
11.7.2 Esaote SpA Business Overview
11.7.3 Esaote SpA Brain Imaging And Neuroimaging Product Models, Descriptions and Specifications
11.7.4 Esaote SpA Brain Imaging And Neuroimaging Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Esaote SpA Recent Developments
11.8 Sanrad Medical Systems
11.8.1 Sanrad Medical Systems Corporation Information
11.8.2 Sanrad Medical Systems Business Overview
11.8.3 Sanrad Medical Systems Brain Imaging And Neuroimaging Product Models, Descriptions and Specifications
11.8.4 Sanrad Medical Systems Brain Imaging And Neuroimaging Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Sanrad Medical Systems Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Brain Imaging And Neuroimaging Industry Chain
12.2 Brain Imaging And Neuroimaging Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Brain Imaging And Neuroimaging Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Brain Imaging And Neuroimaging Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Brain Imaging And Neuroimaging Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Brain Imaging And Neuroimaging Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Brain Imaging And Neuroimaging Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Brain Imaging And Neuroimaging Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Brain Imaging And Neuroimaging Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Brain Imaging And Neuroimaging Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Brain Imaging And Neuroimaging Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Brain Imaging And Neuroimaging Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Brain Imaging And Neuroimaging Sales by Region (2020-2025) & (K Units)
Table 8. Global Brain Imaging And Neuroimaging Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Brain Imaging And Neuroimaging Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Brain Imaging And Neuroimaging Sales Share by Manufacturers (2020-2025)
Table 12. Global Brain Imaging And Neuroimaging Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Brain Imaging And Neuroimaging Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Brain Imaging And Neuroimaging by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Imaging And Neuroimaging as of 2024)
Table 16. Global Brain Imaging And Neuroimaging Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Brain Imaging And Neuroimaging Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Brain Imaging And Neuroimaging Manufacturing Base and Headquarters
Table 19. Global Brain Imaging And Neuroimaging Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Brain Imaging And Neuroimaging Sales by Type (2020-2025) & (K Units)
Table 23. Global Brain Imaging And Neuroimaging Sales by Type (2026-2031) & (K Units)
Table 24. Global Brain Imaging And Neuroimaging Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Brain Imaging And Neuroimaging Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Brain Imaging And Neuroimaging ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Brain Imaging And Neuroimaging Sales by Application (2020-2025) & (K Units)
Table 29. Global Brain Imaging And Neuroimaging Sales by Application (2026-2031) & (K Units)
Table 30. Brain Imaging And Neuroimaging High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Brain Imaging And Neuroimaging Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Brain Imaging And Neuroimaging Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Brain Imaging And Neuroimaging ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Brain Imaging And Neuroimaging Growth Accelerators and Market Barriers
Table 37. North America Brain Imaging And Neuroimaging Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Brain Imaging And Neuroimaging Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Brain Imaging And Neuroimaging Growth Accelerators and Market Barriers
Table 40. Europe Brain Imaging And Neuroimaging Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Brain Imaging And Neuroimaging Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Brain Imaging And Neuroimaging Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Brain Imaging And Neuroimaging Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Brain Imaging And Neuroimaging Growth Accelerators and Market Barriers
Table 45. Southeast Asia Brain Imaging And Neuroimaging Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Brain Imaging And Neuroimaging Investment Opportunities and Key Challenges
Table 47. Central and South America Brain Imaging And Neuroimaging Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Brain Imaging And Neuroimaging Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Brain Imaging And Neuroimaging Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Varian Medical Systems Corporation Information
Table 51. Varian Medical Systems Description and Major Businesses
Table 52. Varian Medical Systems Product Models, Descriptions and Specifications
Table 53. Varian Medical Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Varian Medical Systems Sales Value Proportion by Product in 2024
Table 55. Varian Medical Systems Sales Value Proportion by Application in 2024
Table 56. Varian Medical Systems Sales Value Proportion by Geographic Area in 2024
Table 57. Varian Medical Systems Brain Imaging And Neuroimaging SWOT Analysis
Table 58. Varian Medical Systems Recent Developments
Table 59. General Electric Corporation Information
Table 60. General Electric Description and Major Businesses
Table 61. General Electric Product Models, Descriptions and Specifications
Table 62. General Electric Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. General Electric Sales Value Proportion by Product in 2024
Table 64. General Electric Sales Value Proportion by Application in 2024
Table 65. General Electric Sales Value Proportion by Geographic Area in 2024
Table 66. General Electric Brain Imaging And Neuroimaging SWOT Analysis
Table 67. General Electric Recent Developments
Table 68. Siemens AG Corporation Information
Table 69. Siemens AG Description and Major Businesses
Table 70. Siemens AG Product Models, Descriptions and Specifications
Table 71. Siemens AG Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Siemens AG Sales Value Proportion by Product in 2024
Table 73. Siemens AG Sales Value Proportion by Application in 2024
Table 74. Siemens AG Sales Value Proportion by Geographic Area in 2024
Table 75. Siemens AG Brain Imaging And Neuroimaging SWOT Analysis
Table 76. Siemens AG Recent Developments
Table 77. Philips Healthcare Corporation Information
Table 78. Philips Healthcare Description and Major Businesses
Table 79. Philips Healthcare Product Models, Descriptions and Specifications
Table 80. Philips Healthcare Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Philips Healthcare Sales Value Proportion by Product in 2024
Table 82. Philips Healthcare Sales Value Proportion by Application in 2024
Table 83. Philips Healthcare Sales Value Proportion by Geographic Area in 2024
Table 84. Philips Healthcare Brain Imaging And Neuroimaging SWOT Analysis
Table 85. Philips Healthcare Recent Developments
Table 86. Toshiba Medical Systems Corporation Information
Table 87. Toshiba Medical Systems Description and Major Businesses
Table 88. Toshiba Medical Systems Product Models, Descriptions and Specifications
Table 89. Toshiba Medical Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Toshiba Medical Systems Sales Value Proportion by Product in 2024
Table 91. Toshiba Medical Systems Sales Value Proportion by Application in 2024
Table 92. Toshiba Medical Systems Sales Value Proportion by Geographic Area in 2024
Table 93. Toshiba Medical Systems Brain Imaging And Neuroimaging SWOT Analysis
Table 94. Toshiba Medical Systems Recent Developments
Table 95. Hitachi Medical Systems Corporation Information
Table 96. Hitachi Medical Systems Description and Major Businesses
Table 97. Hitachi Medical Systems Product Models, Descriptions and Specifications
Table 98. Hitachi Medical Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Hitachi Medical Systems Recent Developments
Table 100. Esaote SpA Corporation Information
Table 101. Esaote SpA Description and Major Businesses
Table 102. Esaote SpA Product Models, Descriptions and Specifications
Table 103. Esaote SpA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Esaote SpA Recent Developments
Table 105. Sanrad Medical Systems Corporation Information
Table 106. Sanrad Medical Systems Description and Major Businesses
Table 107. Sanrad Medical Systems Product Models, Descriptions and Specifications
Table 108. Sanrad Medical Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Sanrad Medical Systems Recent Developments
Table 110. Key Raw Materials Distribution
Table 111. Raw Materials Key Suppliers
Table 112. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 113. Milestones in Production Technology Evolution
Table 114. Distributors List
Table 115. Market Trends and Market Evolution
Table 116. Market Drivers and Opportunities
Table 117. Market Challenges, Risks, and Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Brain Imaging And Neuroimaging Product Picture
Figure 2. Global Brain Imaging And Neuroimaging Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Functional Magnetic Resonance Imaging (fMRI) Product Picture
Figure 4. Computed Tomography (CT) Product Picture
Figure 5. Positron Emission Tomography (PET) Product Picture
Figure 6. Global Brain Imaging And Neuroimaging Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Hospitals
Figure 8. Ambulatory Surgical Centers
Figure 9. Clinics and Diagnostic Centers
Figure 10. Brain Imaging And Neuroimaging Report Years Considered
Figure 11. Global Brain Imaging And Neuroimaging Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Brain Imaging And Neuroimaging Revenue (2020-2031) & (US$ Million)
Figure 13. Global Brain Imaging And Neuroimaging Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Brain Imaging And Neuroimaging Revenue Market Share by Region (2020-2031)
Figure 15. Global Brain Imaging And Neuroimaging Sales (2020-2031) & (K Units)
Figure 16. Global Brain Imaging And Neuroimaging Sales (CAGR) by Region (2020-2031) (K Units)
Figure 17. Global Brain Imaging And Neuroimaging Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Brain Imaging And Neuroimaging Sales Volume Market Share in 2024
Figure 19. Global Brain Imaging And Neuroimaging Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Functional Magnetic Resonance Imaging (fMRI) Revenue Market Share by Manufacturer in 2024
Figure 22. Computed Tomography (CT) Revenue Market Share by Manufacturer in 2024
Figure 23. Positron Emission Tomography (PET) Revenue Market Share by Manufacturer in 2024
Figure 24. Global Brain Imaging And Neuroimaging Sales Market Share by Type (2020-2031)
Figure 25. Global Brain Imaging And Neuroimaging Revenue Market Share by Type (2020-2031)
Figure 26. Global Brain Imaging And Neuroimaging Sales Market Share by Application (2020-2031)
Figure 27. Global Brain Imaging And Neuroimaging Revenue Market Share by Application (2020-2031)
Figure 28. North America Brain Imaging And Neuroimaging Sales YoY (2020-2031) & (K Units)
Figure 29. North America Brain Imaging And Neuroimaging Revenue YoY (2020-2031) & (US$ Million)
Figure 30. North America Top 5 Manufacturers Brain Imaging And Neuroimaging Sales Revenue (US$ Million) in 2024
Figure 31. North America Brain Imaging And Neuroimaging Sales Volume (K Units) by Type (2020- 2031)
Figure 32. North America Brain Imaging And Neuroimaging Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 33. North America Brain Imaging And Neuroimaging Sales Volume (K Units) by Application (2020-2031)
Figure 34. North America Brain Imaging And Neuroimaging Sales Revenue (US$ Million) by Application (2020-2031)
Figure 35. US Brain Imaging And Neuroimaging Revenue (2020-2031) & (US$ Million)
Figure 36. Canada Brain Imaging And Neuroimaging Revenue (2020-2031) & (US$ Million)
Figure 37. Mexico Brain Imaging And Neuroimaging Revenue (2020-2031) & (US$ Million)
Figure 38. Europe Brain Imaging And Neuroimaging Sales YoY (2020-2031) & (K Units)
Figure 39. Europe Brain Imaging And Neuroimaging Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Europe Top 5 Manufacturers Brain Imaging And Neuroimaging Sales Revenue (US$ Million) in 2024
Figure 41. Europe Brain Imaging And Neuroimaging Sales Volume (K Units) by Type (2020-2031)
Figure 42. Europe Brain Imaging And Neuroimaging Sales Revenue (US$ Million) by Type (2020-2031)
Figure 43. Europe Brain Imaging And Neuroimaging Sales Volume (K Units) by Application (2020-2031)
Figure 44. Europe Brain Imaging And Neuroimaging Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. Germany Brain Imaging And Neuroimaging Revenue (2020-2031) & (US$ Million)
Figure 46. France Brain Imaging And Neuroimaging Revenue (2020-2031) & (US$ Million)
Figure 47. U.K. Brain Imaging And Neuroimaging Revenue (2020-2031) & (US$ Million)
Figure 48. Italy Brain Imaging And Neuroimaging Revenue (2020-2031) & (US$ Million)
Figure 49. Russia Brain Imaging And Neuroimaging Revenue (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Brain Imaging And Neuroimaging Sales YoY (2020-2031) & (K Units)
Figure 51. Asia-Pacific Brain Imaging And Neuroimaging Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Top 8 Manufacturers Brain Imaging And Neuroimaging Sales Revenue (US$ Million) in 2024
Figure 53. Asia-Pacific Brain Imaging And Neuroimaging Sales Volume (K Units) by Type (2020- 2031)
Figure 54. Asia-Pacific Brain Imaging And Neuroimaging Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 55. Asia-Pacific Brain Imaging And Neuroimaging Sales Volume (K Units) by Application (2020-2031)
Figure 56. Asia-Pacific Brain Imaging And Neuroimaging Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Indonesia Brain Imaging And Neuroimaging Revenue (2020-2031) & (US$ Million)
Figure 58. Japan Brain Imaging And Neuroimaging Revenue (2020-2031) & (US$ Million)
Figure 59. South Korea Brain Imaging And Neuroimaging Revenue (2020-2031) & (US$ Million)
Figure 60. China Taiwan Brain Imaging And Neuroimaging Revenue (2020-2031) & (US$ Million)
Figure 61. India Brain Imaging And Neuroimaging Revenue (2020-2031) & (US$ Million)
Figure 62. Central and South America Brain Imaging And Neuroimaging Sales YoY (2020-2031) & (K Units)
Figure 63. Central and South America Brain Imaging And Neuroimaging Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Central and South America Top 5 Manufacturers Brain Imaging And Neuroimaging Sales Revenue (US$ Million) in 2024
Figure 65. Central and South America Brain Imaging And Neuroimaging Sales Volume (K Units) by Type (2021-2031)
Figure 66. Central and South America Brain Imaging And Neuroimaging Sales Revenue (US$ Million) by Type (2020-2031)
Figure 67. Central and South America Brain Imaging And Neuroimaging Sales Volume (K Units) by Application (2020-2031)
Figure 68. Central and South America Brain Imaging And Neuroimaging Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Brazil Brain Imaging And Neuroimaging Revenue (2020-2025) & (US$ Million)
Figure 70. Argentina Brain Imaging And Neuroimaging Revenue (2020-2025) & (US$ Million)
Figure 71. Middle East, and Africa Brain Imaging And Neuroimaging Sales YoY (2020-2031) & (K Units)
Figure 72. Middle East and Africa Brain Imaging And Neuroimaging Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Middle East and Africa Top 5 Manufacturers Brain Imaging And Neuroimaging Sales Revenue (US$ Million) in 2024
Figure 74. Middle East and Africa Brain Imaging And Neuroimaging Sales Volume (K Units) by Type (2021-2031)
Figure 75. South America Brain Imaging And Neuroimaging Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Middle East and Africa Brain Imaging And Neuroimaging Sales Volume (K Units) by Application (2020-2031)
Figure 77. Middle East and Africa Brain Imaging And Neuroimaging Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. GCC Countries Brain Imaging And Neuroimaging Revenue (2020-2025) & (US$ Million)
Figure 79. Turkey Brain Imaging And Neuroimaging Revenue (2020-2025) & (US$ Million)
Figure 80. Egypt Brain Imaging And Neuroimaging Revenue (2020-2025) & (US$ Million)
Figure 81. South Africa Brain Imaging And Neuroimaging Revenue (2020-2025) & (US$ Million)
Figure 82. Brain Imaging And Neuroimaging Industry Chain Mapping
Figure 83. Regional Brain Imaging And Neuroimaging Manufacturing Base Distribution (%)
Figure 84. Global Brain Imaging And Neuroimaging Production Market Share by Region (2020-2031)
Figure 85. Brain Imaging And Neuroimaging Production Process
Figure 86. Regional Brain Imaging And Neuroimaging Production Cost Structure
Figure 87. Channels of Distribution (Direct Vs Distribution)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Brain Imaging And Neuroimaging market?
The top companies in the global Brain Imaging And Neuroimaging market are Varian Medical Systems、General Electric、Siemens AG.
Related Reports
Brain Imaging And Neuroimaging- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Brain Imaging And Neuroimaging was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 130
USD 3950.00
(Single User License)
Global Brain Imaging And Neuroimaging Market Research Report 2026
The global Brain Imaging And Neuroimaging market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-17
Pages: 117
USD 2900.00
(Single User License)
Global Brain Imaging And Neuroimaging Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Brain Imaging And Neuroimaging market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 80
USD 4250.00
(Single User License)
Brain Imaging And Neuroimaging- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Brain Imaging And Neuroimaging was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 96
USD 3950.00
(Single User License)
Global Brain Imaging And Neuroimaging Market Research Report 2025
The global market for Brain Imaging And Neuroimaging was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 87
USD 2900.00
(Single User License)
Global Brain Imaging And Neuroimaging Market Research Report 2024
The global Brain Imaging And Neuroimaging market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-05
Pages: 83
USD 2900.00
(Single User License)
Brain Imaging And Neuroimaging- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Brain Imaging And Neuroimaging was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 130
USD 3950.00 (Single User License)Global Brain Imaging And Neuroimaging Market Research Report 2026
The global Brain Imaging And Neuroimaging market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 117
USD 2900.00 (Single User License)Global Brain Imaging And Neuroimaging Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Brain Imaging And Neuroimaging market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 80
USD 4250.00 (Single User License)Brain Imaging And Neuroimaging- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Brain Imaging And Neuroimaging was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 96
USD 3950.00 (Single User License)Global Brain Imaging And Neuroimaging Market Research Report 2025
The global market for Brain Imaging And Neuroimaging was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 87
USD 2900.00 (Single User License)Global Brain Imaging And Neuroimaging Market Research Report 2024
The global Brain Imaging And Neuroimaging market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-05
Pages: 83
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now